https://www.selleckchem.com/pr....oducts/gw-441756.htm
Stratification of diabetes in risk categories revealed benefits (p interaction=0·0864) only in patients with concomitant hypertension and hypercholesterolemia (OR0·87, 95% CI0·65-1·15), but not in smokers. STEMI was strongly related to 30-day mortality (OR1·93; 95%CI1·59-2·35). Low-dose aspirin reduces the risk of STEMI as initial manifestation of CV disease with potential benefit in mortality. Patients with diabetes derive substantial benefit from aspirin only in the presence of multiple risk factors. #link# In the era of precision m
Like
Comment
Share
